EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pyruvate Kinase M2: A New Biomarker for the Early Detection of Diabetes-Induced Nephropathy

Yeon Su Park, Joo Hee Han iD, Jae Hyeon Park, Ji Soo Choi, Seung Hyeon Kim, Hyung Sik Kim iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032683 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Yeon Su Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Diabetes Mellitus. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF) grant funded by the Korean Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic nephropathy (DN) is a common complication of diabetes. DN progresses to end-stage renal disease, which has a high mortality rate. Current research is focused on identifying non-invasive potential biomarkers in the early stage of DN. We previously indicated that pyruvate kinase M2 (PKM2) is excreted in the urine of rats after cisplatin-induced acute kidney injury (AKI). However, it has not been reported whether PKM2 can be used as a biomarker to diagnose DN. Therefore, we try to compare whether the protein PKM2 can be detected in the urine samples from diabetic patients as shown in the results of DN models. In this study, high-fat diet (HFD)-induced Zucker diabetic fatty (ZDF) rats were used for DN phenotyping. After 19 weeks of receiving a HFD, the DN model’s blood glucose, blood urea nitrogen, and serum creatinine levels were significantly increased; severe tubular and glomerular damages were also noted. The following protein-based biomarkers were increased in the urine of these models: kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), and PKM2. PKM2 had the earliest detection rate. In the urine samples of patients, PKM2 protein was highly detected in the urine of diabetic patients but was not excreted in the urine of normal subjects. Therefore, PKM2 was selected as the new biomarker for the early diagnosis of DN. Our results reflect current knowledge on the role of PKM2 in DN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesDiabetes MellitusRatsAnimalsPyruvate KinaseRats, ZuckerLipocalin-2Early DiagnosisBiomarkers

Stichwörter der Autor:innen

biomarkerdiabetesnephropathypyruvate kinase M2urinary excretion

Substanzen

Pyruvate KinaseLipocalin-2Biomarkers

Autor:innen und Institutionen

  • School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
  • St. Mark's School, 25 Marlboro Rd, Southborough, MA 01772, USA.

ORCID-Profile: Joo Hee Han, Hyung Sik Kim

Förderung

  • National Research Foundation of Korea (NRF) grant funded by the Korean Government

Zitieren

APA

Park, Y. S., Han, J. H., Park, J. H., Choi, J. S., Kim, S. H., & Kim, H. S. (2023). Pyruvate Kinase M2: A New Biomarker for the Early Detection of Diabetes-Induced Nephropathy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032683

Vancouver

Park YS, Han JH, Park JH, Choi JS, Kim SH, Kim HS. Pyruvate Kinase M2: A New Biomarker for the Early Detection of Diabetes-Induced Nephropathy. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032683

BibTeX
@article{Park2023,
  author = {Park, Yeon Su and Han, Joo Hee and Park, Jae Hyeon and Choi, Ji Soo and Kim, Seung Hyeon and Kim, Hyung Sik},
  title = {Pyruvate Kinase M2: A New Biomarker for the Early Detection of Diabetes-Induced Nephropathy},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032683}
}
Kostenlos starten →